Mandy Reeves, recognized as one of the top antitrust lawyers in the world, is a partner in the Litigation & Trial Department. She is the Office Managing Partner of the Washington, D.C. office, and formerly served as Global Chair of Latham’s Band 1 Global Antitrust & Competition Practice.

Ms. Reeves is a sought after global leader in the antitrust bar, who clients turn to for sophisticated advice and representation in their toughest matters. She secures key victories for clients, whether it involves developing a creative strategy to work constructively with global regulators when obtaining regulatory approval, aggressively proceeding through trial successfully, or advising and leading the charge in defending novel monopolization claims in confidential investigations or landmark litigations. Her work cuts across all industries including high-tech, entertainment, sports, media, communications, life sciences, healthcare, semiconductors, agriculture, automotive, retail, and consumer products.

Recently, over the span of 6 months, Ms. Reeves successfully tried two antitrust merger litigations against the DOJ (U.S. Sugar/Imperial Sugar and Booz-Allen/Everwatch), in addition to obtaining unconditional clearance for MGM’s US$7 billion sale to Amazon and Affera’s US$1 billion sale to Medtronic following FTC Second Requests, among others.

In recognition of her work spanning antitrust litigation, antitrust investigations, and complex merger control matters: Global Competition Review (GCR), the world’s leading antitrust publication, recently named her the top Global Competition Lawyer of the Year; The Deal recognized her as a “Top Woman in Dealmaking” (2023); and GCR honored Ms. Reeves and her team with Matter of the Year (2023). She is also a past finalist for GCR’s Dealmaker of the Year and Legal Media Group’s Life Sciences Antitrust Litigator of the Year. She is recognized by ChambersThe Legal 500, Benchmark Litigation, and has been named a Who’s Who Global Thought Leader in Competition law.

Ms. Reeves previously served as Attorney Advisor to Commissioner J. Thomas Rosch at the Federal Trade Commission and is a sought after speaker and writer on antitrust issues. She is an active member of the American Bar Association’s Antitrust Section, where she previously served on the Section’s Governing Council and chairs the Annual Law & Economics Institute for Judges, a three-day intensive training program, which trains federal judges in antitrust law and economics.

Ms. Reeves has served in multiple management roles at Latham including her previous position as the Global Chair of the firm’s Mentoring Committee. She is a past Finalist for the American Lawyer’s Mentor of the Year.

Prior to joining Latham, Ms. Reeves clerked for Judge Mary Beck Briscoe, former Chief Judge of the United States Court of Appeals for the Tenth Circuit and for Judge John G. Heyburn II, Chief Judge of the United States District Court for the Western District of Kentucky.

Representative matters include advising/representing:

Representative Merger Matters

High Technology

  • Intuit in its US$7.1 billion acquisition of Credit Karma
  • AMD in its US$35 billion acquisition of Xilinx
  • Tower Semiconductor in its US$5.9 billion sale to Intel
  • Okta in its US$6.5 billlion acquisition of Auth0
  • Orbitz in its US$1.6 billion sale to Expedia

Healthcare and Life Sciences

  • Cerner in its US$30 billion sale to Oracle
  • Affera in its US$1 billion sale to Medtronic
  • ANI Pharmaceuticals in its acquisition of Novitium
  • Amneal Pharmaceuticals in its US$1.4 billion merger with Impax Laboratories
  • Integra LifeSciences Holdings Corporation in its US$1.05 billion acquisition of Johnson & Johnson’s Codman Neurosurgery business
  • ArthroCare in its US$1.7 billion acquisition by Smith & Nephew
  • Receptos in its US$7.2 billion purchase by Celgene

Entertainment and Media

  • MGM in its US$8.5 billion sale to Amazon
  • Entercom Communications in connection with its acquisition of CBS Radio
  • Endeavor in numerous transactions including acquisition of OpenBet and sale of Endeavor Content

Industrial and Automotive

  • GCP in its US$2.3 billion sale to Saint Gobain
  • Novelis in its US$2.6 billion acquisition of Aleris
  • FXI in its acquisition of Innocor
  • Nissan in its acquisition of a US$2.2 billion controlling stake in Mitsubishi Motors, winning 14 unconditional clearances globally
  • The Carlyle Group’s Veyance in its US$1.8 billion sale to Continental AG


  • U.S. Sugar in its acquisition of Imperial Sugar
  • Agrium in its US$36 billion merger of equals with Potash Corp

Representative Litigation Matters

  • Everwatch in the DOJ’s novel Section 1 challenge to its sale to Booz-Allen Hamilton. The Latham team prevailed in a matter that went from Complaint to a federal bench trial in 2.5 months.
  • U.S. Sugar in the DOJ’s Section 7 challenge to its acquisition of Imperial Sugar. The Latham team prevailed following a week-long trial in a matter that went from Complaint to trial in less than 5 months.
  • Surescripts in ongoing Section 2 monopolization litigation opposite the FTC and follow-on class actions.
  • American Red Cross in ongoing Sherman Act litigation.
  • DoorDash in antitrust litigation alleging a conspiracy among food delivery companies to implement contractual terms; DoorDash was successfully removed from the case.
  • Genentech in antitrust litigation alleging it engaged in anticompetitive conduct in conjunction with pharmaceutical products; Latham prevailed following a motion to dismiss and on appeal in the Second Circuit.
  • Actavis in successful antitrust litigation involving a novel refusal to deal claim.

Bar Qualification

  • District of Columbia
  • Virginia


  • JD, University of Virginia School of Law, 2002
  • MA, University of Virginia, 2002
  • BA, University of Virginia, 1999